A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
Condition: Healthy Subjects Intervention: Drug: DW6012 Sponsor: Dong Wha Pharmaceutical Co. Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes
Conditions: Diabetes Mellitus, Type 2; Severe Insulin Deficient Diabetes Interventions: Drug: Glimepiride; Drug: Sitagliptin Sponsors: Peking University People's Hospital; Peking University First Hospital; Jiangsu Province Geriatric Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2022 Category: Research Source Type: clinical trials